New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
aTyr Pharma, Inc.
LIFE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

131M

Biotechnology

Next Earning date - 22 May 2025

131M

Biotechnology

Next Earning date - 22 May 2025

1.90USD

Shape0.05 ( 2.70%)
Market Closed (as of Jun 04, 20:00 EDT)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

22%

Quote Panel

Shape
Updated March 20, 2025
1W % 1M % 3M % 1Y -24.75 %

Key Metrics

Shape
  • Market Cap

    131.12M


  • Shares Outstanding

    69.01M


  • Share in Float

    67.12M


  • Dividende

    0


  • Earning Date

    22 May 2025


  • Price Target

    1.9


  • Average Volume

    480976


  • Beta

    1.188


  • Range

    1.0801-2.45


  • Industry

    Biotechnology


  • Website

    https://www.atyrpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LIFE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7M

Shape3071%

2025-Revenue

$0.75

Shape-225%

2025-EPS

$4M

Shape72%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Oppenheimer

downgrade

Previous: Not converted

2023-07-05

Now: Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.44
vs -0.64

Q3.22

arrow
arrow

N/A

-0.46
vs -0.42

Q4.22

arrow
arrow

N/A

-0.26
vs -0.31

Q1.23

arrow
arrow

N/A

-0.29
vs -0.44

Q2.23

arrow
arrow

N/A

-0.22
vs -0.44

Q3.23

arrow
arrow

N/A

-0.20
vs -0.46

Q4.23

arrow
arrow

N/A

-0.25
vs -0.26

Q1.24

arrow
arrow

N/A

-0.23
vs -0.29

Q3.24

arrow
arrow

N/A

-0.24
vs -0.20

Q4.24

arrow
arrow

N/A

-0.24
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

10.4M  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

353K  vs NA

Q4.23

arrow
arrow

-58%

4.3M  vs 10.4M

Q1.24

arrow
arrow

NA

235K  vs NA

Q3.24

arrow
arrow

-91%

30K  vs 353K

Q4.24

arrow
arrow

-99%

32.5K  vs 4.3M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-14%

-0.14
vs -0.12

Q3.22

arrow
arrow

-17%

-0.17
vs -0.14

Q4.22

arrow
arrow

-10%

-0.10
vs -0.17

Q1.23

arrow
arrow

-10%

-0.10
vs -0.10

Q2.23

arrow
arrow

-12%

-0.12
vs -0.10

Q3.23

arrow
arrow

-12%

-0.12
vs -0.12

Q4.23

arrow
arrow

-16%

-0.16
vs -0.12

Q1.24

arrow
arrow

-18%

-0.18
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

39

39
vs 39

NA

Q2.23

arrow
arrow

45

45
vs 39

15%

Q3.23

arrow
arrow

44

44
vs 45

-2%

Q4.23

arrow
arrow

48

48
vs 44

9%

Q1.24

arrow
arrow

58

58
vs 48

21%

Q2.24

arrow
arrow

49

49
vs 58

-16%

Q3.24

arrow
arrow

58

58
vs 49

18%

Q4.24

arrow
arrow

82

82
vs 58

41%

Earnings Growth

Latest News